Duck Disease: Comprehensive Guide to Common Pathogens in Ducks
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Riemerella anatipestifer causes septicemic "New Duck Disease" in ducklings (2-7 weeks old), characterized by fibrinous pericarditis, perihepatitis, and airsacculitis; diagnosis relies on isolation and 16S rRNA gene sequencing, with control through biosecurity and bacterins.
- Pasteurella multocida (fowl cholera) presents as acute septicemia or chronic localized infections in mature ducks, diagnosed via culture and confirmed by bipolar staining, with treatment using tetracyclines or sulfonamides and prevention via inactivated bacterins.
- Salmonella enterica infections in ducks, particularly in eastern China, exhibit high multidrug resistance (e.g., to tetracycline and ampicillin), necessitating isolation from feces or tissues and treatment based on susceptibility testing.
- Duck plague (Duck Viral Enteritis), caused by a herpesvirus, leads to high mortality with hemorrhagic lesions in the digestive tract; diagnosis is confirmed by virus isolation or PCR, and control is achieved through vaccination and strict biosecurity.
- Duck Viral Hepatitis (DHV), caused by DHAV genotypes 1-3, is a highly contagious disease of ducklings with neurological signs and liver necrosis, diagnosed by RT-PCR and controlled with live/inactivated vaccines or passive immunization with IgY.
- Emerging viruses like Duck Tembusu Virus (DTMUV) cause significant egg drop and neurological signs in laying ducks, transmitted by mosquitoes and diagnosed via RT-PCR, with control through vaccination and mosquito abatement.
Introduction
Duck diseases represent a significant challenge to commercial waterfowl production, causing substantial economic losses through mortality, reduced growth performance, and trade restrictions [5, 18]. The term "duck disease" encompasses a broad spectrum of infectious and non-infectious conditions affecting domestic and wild ducks. This guide provides a detailed, evidence-based review of the major bacterial and viral pathogens of ducks, with a focus on etiology, epidemiology, clinical signs, pathology, diagnostics, treatment, and control. Understanding the question "what is ducks disease" requires a systematic examination of the specific etiological agents that cause morbidity and mortality in duck populations [<a href="#ref-1">1</a>, 5].
Bacterial Pathogens
Riemerella anatipestifer (New Duck Disease)
Riemerella anatipestifer is a Gram-negative, non-motile, rod-shaped bacterium that causes a septicemic disease known as New Duck disease, primarily in domestic ducks [<a href="#ref-2">2</a>, 11]. The bacterium is a member of the family Flavobacteriaceae and is characterized by its fastidious growth requirements, typically cultured on blood agar or tryptic soy agar under microaerophilic conditions [11, 12].
Etiology and Epidemiology. R. anatipestifer is the causative agent of New Duck disease, a condition historically referred to as "duck septicemia" or "infectious serositis". The pathogen is highly contagious and spreads horizontally through direct contact, contaminated water, and fomites. Outbreaks are most common in ducklings aged 2 to 7 weeks, with morbidity rates reaching 50% and mortality rates varying from 5% to 75% depending on the virulence of the strain and management conditions. Genomic diversity among isolates has been documented, with molecular fingerprinting using ERIC-PCR revealing 10 to 12 bands per isolate ranging from 150 bp to 2000 bp, indicating substantial genetic variation among field strains. Phylogenetic analysis of these fingerprints has shown that variants from commercial flocks are genetically more diverse compared to isolates from organized instructional farms.
Clinical Signs and Pathology. Affected ducklings present with acute onset of depression, ataxia, opisthotonos, and diarrhea [11, 12]. Postmortem examination typically reveals fibrinous pericarditis, perihepatitis, and airsacculitis, often accompanied by caseous exudate in the peritoneal cavity. The bacterium can cross the blood-brain barrier, leading to meningitis. The OmpA protein of R. anatipestifer has been identified as a key virulence factor mediating invasion of duck brain microvascular endothelial cells (DBMECs) and penetration of the duckling blood-brain barrier. Specifically, amino acids 230-242 of OmpA represent a critical domain involved in this invasion process.
Diagnostics. Definitive diagnosis relies on bacterial isolation from liver, heart blood, or brain tissue, followed by biochemical identification or 16S rRNA gene sequencing [<a href="#ref-2">2</a>, 11]. Species-specific PCR assays targeting the 16S rRNA gene provide rapid and sensitive detection, with 99% sequence similarity to the reference strain ATCC 11845.
Treatment and Control. Antimicrobial therapy is guided by susceptibility testing, as resistance patterns vary geographically. Control measures include strict biosecurity, all-in-all-out management, and vaccination with autogenous or commercial bacterins [5, 11].
Pasteurella multocida (Fowl Cholera)
Pasteurella multocida is a Gram-negative, bipolar-staining coccobacillus that causes fowl cholera, a highly contagious septicemic disease affecting ducks, chickens, and other avian species. In ducks, the disease is often referred to as duck cholera and is the second most prevalent duck disease in some regions, with a reported prevalence of 28% in passive surveillance studies.
Etiology and Epidemiology. P. multocida serotypes A and D are most commonly associated with fowl cholera in ducks. Transmission occurs via respiratory droplets, contaminated feed and water, and through carrier birds. Outbreaks are more frequent in mature ducks, with one study reporting a higher frequency in young-aged ducks (33.96%) compared to mature birds, and no prevalence observed in birds aged above 269 days.
Clinical Signs and Pathology. Acute infections present with sudden death, fever, depression, and mucoid discharge from the mouth and nares. Chronic infections may manifest as localized swelling of the wattles, sinuses, and joints. Postmortem findings include petechial hemorrhages on the heart and serosal surfaces, hepatomegaly with multifocal necrosis, and splenomegaly.
Diagnostics. Diagnosis is confirmed by bacterial culture from blood, liver, or bone marrow, with Gram staining revealing characteristic bipolar staining. Molecular methods, including species-specific PCR, are used for rapid detection and serotyping.
Treatment and Control. Antibiotics such as tetracyclines, sulfonamides, and fluoroquinolones are effective, though antimicrobial resistance is an emerging concern. Vaccination with inactivated bacterins provides protection, and biosecurity measures are critical for prevention.
Salmonella enterica (Salmonellosis)
Salmonella enterica is a Gram-negative, facultative anaerobic rod that causes salmonellosis in ducks, with significant zoonotic implications. Duck farms in eastern China have shown a significantly higher prevalence of Salmonella (19.17%) compared to chicken farms (6.61%) and pig farms (3.50%).
Etiology and Epidemiology. Multiple serovars of S. enterica infect ducks, including S. Enteritidis, S. Typhimurium, and S. Indiana [8, 27]. The bacterium is shed in feces and can contaminate eggs, leading to vertical transmission. Whole-genome sequencing of isolates from duck farms has revealed high rates of multidrug resistance (75.26%), with the highest resistance rates to tetracycline (76.20%) and ampicillin (67.62%). The most frequent serotype in one study was S. Kentucky (20.95%), which harbored more antimicrobial resistance patterns and genes than other serotypes.
Clinical Signs and Pathology. Clinical signs in ducklings include diarrhea, dehydration, depression, and increased mortality. In older ducks, infection is often subclinical, but carriers can shed the bacterium intermittently. Co-infection with other pathogens, such as duck reovirus, can exacerbate disease severity.
Diagnostics. Isolation of Salmonella from fecal samples, cloacal swabs, or tissues using selective media (e.g., MacConkey agar, XLD agar) is standard. Serotyping and antimicrobial susceptibility testing are essential for epidemiological surveillance and treatment guidance. Molecular methods, including PCR and whole-genome sequencing, provide high-resolution typing and resistance gene profiling.
Treatment and Control. Antimicrobial therapy should be based on susceptibility testing due to widespread resistance. Control measures include biosecurity, all-in-all-out management, and monitoring of feed and water sources.
Escherichia coli (Colibacillosis)
Escherichia coli is a Gram-negative, facultative anaerobic rod that is a common cause of colibacillosis in ducks, often secondary to viral or environmental stressors. Pathogenic strains of E. coli, particularly those with virulence factors such as fimbriae and toxins, can cause systemic disease.
Etiology and Epidemiology. Avian pathogenic E. coli (APEC) strains are associated with respiratory and septicemic disease in ducks. Colibacillosis is frequently reported in passive surveillance studies, with prevalence rates varying by region and management system.
Clinical Signs and Pathology. Clinical signs include respiratory distress, depression, and diarrhea. Postmortem findings include airsacculitis, pericarditis, perihepatitis, and fibrinous exudates in the coelomic cavity.
Diagnostics. Bacterial culture from affected tissues (liver, spleen, air sacs) on MacConkey agar yields lactose-fermenting colonies. Serotyping and virulence gene profiling by PCR can differentiate APEC from commensal strains.
Treatment and Control. Antimicrobial therapy is guided by susceptibility testing. Control relies on reducing environmental stressors, improving ventilation, and maintaining clean drinking water.
Clostridium botulinum Type C (Botulism)
Clostridium botulinum type C produces a potent neurotoxin that causes botulism in ducks, a condition historically known as "Western duck disease". The bacterium is a Gram-positive, spore-forming, obligate anaerobic rod.
Etiology and Epidemiology. Botulism in ducks is typically associated with the ingestion of preformed toxin in decaying organic matter, carcasses, or invertebrate larvae. Outbreaks are often linked to warm, stagnant water conditions that favor bacterial growth and toxin production.
Clinical Signs and Pathology. Clinical signs include progressive flaccid paralysis of the legs, wings, and neck (limberneck), leading to respiratory failure and death. Affected ducks are unable to hold their heads up and may drown if in water.
Diagnostics. Diagnosis is based on clinical signs, history of exposure, and detection of botulinum toxin in serum or gastrointestinal contents using a mouse bioassay or ELISA.
Treatment and Control. Treatment is supportive, with administration of type-specific antitoxin if available. Control involves removal of carcasses, drainage of stagnant water, and prevention of access to decaying organic material.
Viral Pathogens
Duck Plague (Duck Viral Enteritis)
Duck plague, also known as duck viral enteritis (DVE), is caused by duck plague virus (DPV), a member of the family Herpesviridae, subfamily Alphaherpesvirinae. DPV is a significant pathogen of ducks, geese, and swans, causing high morbidity and mortality. In a retrospective study in Sylhet, Bangladesh, duck plague was the most prevalent duck disease, accounting for 45.3% of cases.
Etiology and Epidemiology. DPV is a double-stranded DNA virus with an envelope. The virus is transmitted horizontally through direct contact, contaminated water, and fomites. The UL49.5 protein of DPV, a homologue of glycoprotein N (gN), is involved in viral attachment, penetration, and cell-to-cell spread. Deletion of UL49.5 results in attachment reduced to approximately 25% of the revertant virus and penetration ability reaching only 73% of the revertant virus. The plaque sizes produced by UL49.5-deleted virus are approximately 58% smaller than those produced by the revertant virus.
Clinical Signs and Pathology. Clinical signs include sudden death, depression, anorexia, photophobia, and watery diarrhea. Postmortem findings include hemorrhagic lesions on the mucosa of the esophagus, intestine, and cloaca, as well as petechial hemorrhages on the heart and liver. The disease is more common in mature ducks, with one study reporting 66.20% prevalence in mature ducks compared to younger birds.
Diagnostics. Diagnosis is based on clinical signs, gross pathology, and histopathology. Virus isolation in embryonated duck eggs or cell culture, followed by neutralization tests, is confirmatory. PCR assays targeting DPV-specific genes are widely used for rapid detection.
Treatment and Control. There is no specific antiviral treatment for duck plague. Control relies on vaccination with live attenuated vaccines and strict biosecurity measures.
Duck Viral Hepatitis (Duck Hepatitis A Virus)
Duck viral hepatitis (DVH) is a highly contagious, acute, and fatal disease of ducklings caused by Duck Hepatitis A virus (DHAV), a member of the family Picornaviridae, genus Avihepatovirus [<a href="#ref-3">3</a>, 23]. The disease is characterized by neurological signs and liver enlargement with spot-like hemorrhages. A proposed disease classification system for DVH has been developed to address the historical confusion caused by multiple hepatotropic viruses being associated with the same disease name [<a href="#ref-3">3</a>]. This system, based on the nomenclature of human viral hepatitis and Koch's postulates, proposes 10 types of disease names to facilitate scientific communication [<a href="#ref-3">3</a>].
Etiology and Epidemiology. DHAV is classified into three genotypes: DHAV-1, DHAV-2, and DHAV-3 [23, 31]. DHAV-1 and DHAV-3 are the most prevalent genotypes in Asia, while DHAV-2 has been reported in India. The virus is highly contagious, spreading via the fecal-oral route, and causes high mortality in ducklings under 6 weeks of age. In recent years, the mutation and recombination of epidemic strains, outbreaks of DHAV-3, and rising mixed infections have posed challenges to disease control.
Clinical Signs and Pathology. Affected ducklings present with opisthotonos, ataxia, and sudden death. Postmortem findings include an enlarged, pale liver with petechial and ecchymotic hemorrhages, and a swollen, mottled spleen. Histopathology reveals severe hepatocellular necrosis and inflammation.
Diagnostics. Diagnosis is based on clinical signs, gross pathology, and histopathology. Virus isolation in embryonated duck eggs or cell culture is confirmatory. Molecular methods, including RT-PCR and real-time RT-PCR, are widely used for rapid detection and genotyping [7, 15]. A triplex real-time PCR assay has been developed for simultaneous detection of DHAV-1, DHAV-3, and other duck viruses. A multiplex RT-qPCR method using TaqMan probes has been developed for simultaneous detection of DHAV-1, DHAV-3, novel duck reovirus, and duck Tembusu virus, with detection limits of 6.03 x 10^1 and 1.88 x 10^2 copies/μL for DHAV-1 and DHAV-3, respectively. Additionally, an RPA-CRISPR Cas12a/Cas13a one-pot strategy (DRCFS) has been developed for rapid detection of DHAV-3 and novel duck reovirus, with a detection limit of 100 copies/μL.
Treatment and Control. There is no specific antiviral treatment for DVH. Control relies on vaccination with live attenuated or inactivated vaccines. Passive immunization with yolk antibodies (IgY) has shown promise, with a dose of 0.5 mL per duckling (containing 64 mg/mL of IgY) significantly reducing DHAV-related mortality by 66%. Selective breeding for resistance to DHAV-3 has been successful, with mortality rates reduced from 59.2% to 7.8% in a resistant line of Pekin ducks.
Duck Tembusu Virus (DTMUV)
Duck Tembusu virus (DTMUV) is an emerging pathogenic flavivirus that causes massive economic losses in the duck industry, particularly in China [7, 29]. The virus is transmitted by mosquitoes and causes a disease characterized by severe egg drop and neurological signs [7, 29].
Etiology and Epidemiology. DTMUV is a single-stranded, positive-sense RNA virus belonging to the family Flaviviridae, genus Flavivirus. The virus is classified into multiple clusters, with Cluster 2 being prevalent in ducks and Cluster 3.2 emerging in chickens. Chicken-origin Cluster 3.2 TMUV exhibits higher infectivity in chicks and ducklings compared to duck-origin Cluster 2 strains. DTMUV is transmitted by mosquitoes and through direct contact.
Clinical Signs and Pathology. Clinical signs in laying ducks include a sudden drop in egg production, depression, anorexia, and neurological signs such as ataxia and tremors. Postmortem findings include ovarian hemorrhage, follicular degeneration, and splenomegaly.
Diagnostics. Diagnosis is based on clinical signs, virus isolation in cell culture (e.g., chicken embryo fibroblasts), and molecular detection [7, 29]. A triplex real-time PCR assay has been developed for simultaneous detection of DTMUV, avian influenza virus, and Newcastle disease virus, with a detection limit of 1 x 10^1 copies/μL. A multiplex digital PCR (dPCR) method has also been developed for simultaneous detection of DTMUV, duck circovirus, and new duck reovirus, with a detection limit of 1.3 copies/μL, which is 10 times higher than multiplex qPCR.
Treatment and Control. There is no specific antiviral treatment. Control relies on vaccination with live attenuated vaccines, such as the FX2010-180P strain, which provides complete protection against virulent challenge. Mosquito control and biosecurity measures are also important.
Newcastle Disease Virus (NDV)
Newcastle disease virus (NDV) is a member of the family Paramyxoviridae, genus Avulavirus, and causes Newcastle disease (ND) in many avian species [7, 30]. Ducks are generally considered natural reservoirs of NDV, but virulent strains can cause disease in ducks, particularly in young birds.
Etiology and Epidemiology. NDV is a single-stranded, negative-sense RNA virus classified into multiple genotypes [16, 21]. Ducks can carry velogenic strains without showing clinical signs, as demonstrated by the isolation of a genotype XVII strain from an apparently healthy domestic duck in Nigeria. However, experimental infection of ducks with a duck-origin virulent NDV strain (JSD0812) has shown that susceptibility varies by breed, with mallard ducks being the most susceptible and Pekin ducks the most resistant. Susceptibility decreases with age, with most deaths occurring in 15- and 30-day-old ducklings.
Clinical Signs and Pathology. Clinical signs in ducks include neurological signs such as ataxia, torticollis, and paralysis. Postmortem findings may include hemorrhagic lesions in the proventriculus and intestine.
Diagnostics. Diagnosis is based on virus isolation in embryonated chicken eggs, hemagglutination inhibition (HI) tests, and molecular detection by RT-PCR [7, 30]. A triplex real-time PCR assay has been developed for simultaneous detection of NDV, avian influenza virus, and duck Tembusu virus.
Treatment and Control. There is no specific antiviral treatment. Control relies on vaccination with live attenuated or inactivated vaccines. A duck-origin NDV strain (NDRL0901) has been developed as a live vaccine candidate, providing significant protection efficacy (>80%) against very virulent NDV in chickens.
Duck Circovirus (DuCV)
Duck circovirus (DuCV) is a small, nonenveloped, single-stranded DNA virus with immunosuppressive effects on ducks [22, 25]. DuCV infection leads to slow growth, feather loss, and elevated mortality following mixed infections.
Etiology and Epidemiology. DuCV is a member of the family Circoviridae, genus Circovirus. The virus has a circular genome of approximately 1995-1996 bp and contains three major open reading frames: ORFV1 (Rep protein), ORFC1 (Cap protein), and ORFC2 (apoptosis-related protein). DuCV is classified into two genotypes, with genotype I being further subdivided into sub-genotypes. The virus is prevalent worldwide, with infection rates increasing in recent years. In Thailand, DuCV isolates circulating belong to genotype I, with at least two sub-genotypes identified.
Clinical Signs and Pathology. Clinical signs include feather loss, emaciation, poor growth performance, and immunosuppression [22, 25]. Postmortem findings include atrophy of the bursa of Fabricius and spleen. Co-infections with other pathogens, such as Riemerella anatipestifer, Escherichia coli, and duck Tembusu virus, are commonly observed due to the immunosuppressive effects of DuCV.
Diagnostics. Diagnosis is based on PCR detection of DuCV DNA in bursa of Fabricius or spleen samples [24, 25]. A quadruplex real-time quantitative PCR method has been developed for simultaneous detection of DuCV, Muscovy duck parvovirus, goose parvovirus, and duck adenovirus 3, with a detection limit of 1 copy/μL for DuCV.
Treatment and Control. There is no specific antiviral treatment. Control relies on biosecurity measures and management practices to reduce stress and prevent co-infections. Vaccines and antiviral therapies are under development.
Duck Reovirus (DRV)
Duck reovirus (DRV) is a member of the family Reoviridae, genus Orthoreovirus, and causes a range of diseases in ducks, including duck spleen necrosis disease (DSND). Novel duck reovirus (NDRV) is an emerging pathogen that causes substantial economic losses in the duck industry [15, 17].
Etiology and Epidemiology. DRV is a non-enveloped, double-stranded RNA virus with a segmented genome consisting of 10 segments. The genome of a DRV strain (DRV/GX-Y7) isolated from DSND cases was 23,418 bp in length, with segments ranging from 3959 nt (L1) to 1191 nt (S4). Phylogenetic analysis showed that this strain belongs to a new waterfowl-origin reovirus cluster, distinct from Muscovy duck reovirus (MDRV) and goose-origin reovirus (GRV). Genetic reassortment events have been identified in the M2 and S1 segments.
Clinical Signs and Pathology. Clinical signs of DSND include depression, anorexia, and sudden death. Postmortem findings include severe hemorrhagic and/or necrotic lesions in the immune organs (thymus, spleen, and bursae). Co-infection with Salmonella indiana can greatly enhance pathogenesis, increasing morbidity and mortality.
Diagnostics. Diagnosis is based on virus isolation in cell culture (e.g., Vero, LMH, DF-1, and DEF cells) and molecular detection by RT-PCR [8, 15]. A multiplex RT-qPCR method has been developed for simultaneous detection of NDRV, DHAV-1, DHAV-3, and DTMUV, with a detection limit of 1.24 x 10^2 copies/μL for NDRV. An RPA-CRISPR Cas12a/Cas13a one-pot strategy (DRCFS) has also been developed for rapid detection of NDRV and DHAV-3, with a detection limit of 100 copies/μL.
Treatment and Control. There is no specific antiviral treatment. Control relies on biosecurity measures and management practices to prevent co-infections.
Other Viral Pathogens
Other viral pathogens affecting ducks include Muscovy duck parvovirus (MDPV), goose parvovirus (GPV), and duck adenovirus 3 (DAdV-3). These viruses can cause significant morbidity and mortality, particularly in young birds. A quadruplex real-time quantitative PCR method has been developed for simultaneous detection of MDPV, GPV, DuCV, and DAdV-3, with detection limits of 10, 10, 1, and 10 copies/μL, respectively.
Diagnostic Approaches
Diagnostic approaches for duck diseases include clinical examination, gross pathology, histopathology, virus isolation, bacterial culture, serology, and molecular methods [5, 7, 15]. Molecular methods, including PCR, real-time PCR, digital PCR, and CRISPR-based assays, offer high sensitivity and specificity for rapid detection of pathogens [7, 15, 17, 26]. Multiplex assays allow simultaneous detection of multiple pathogens, which is particularly important given the high prevalence of co-infections in duck populations [7, 15, 24, 26].
flowchart TD
A["Clinical Signs in Ducks"] --> B{"Initial Assessment"}
B --> C["Neurological Signs"]
B --> D["Respiratory Signs"]
B --> E["Digestive Signs"]
B --> F["Egg Drop"]
C --> G["Suspect DHAV, NDV, or Botulism"]
D --> H["Suspect Fowl Cholera or Colibacillosis"]
E --> I["Suspect Duck Plague or Salmonellosis"]
F --> J["Suspect DTMUV or NDV"]
G --> K["Collect Brain, Liver, Serum"]
H --> K["Collect Lung, Air Sac, Liver"]
I --> K["Collect Intestine, Liver, Feces"]
J --> K["Collect Ovarian Tissue, Cloacal Swab"]
K --> L{"Laboratory Diagnostics"}
L --> M["Bacterial Culture & Sensitivity"]
L --> N["Virus Isolation in Eggs/Cells"]
L --> O["Molecular Detection: PCR, qPCR, dPCR"]
L --> P["Serology: HI, ELISA"]
M --> Q["Identify Bacterial Pathogen"]
N --> R["Identify Viral Pathogen"]
O --> S["Confirm Pathogen & Genotype"]
P --> T["Detect Antibodies"]
Q --> U["Antimicrobial Therapy"]
R --> U["Supportive Care & Vaccination"]
S --> U["Targeted Control Measures"]
T --> U["Vaccination & Biosecurity"]Treatment and Control
Treatment of bacterial infections in ducks is guided by antimicrobial susceptibility testing due to widespread resistance [5, 27]. For viral infections, there are no specific antiviral treatments, and control relies on vaccination, biosecurity, and management practices [5, 23]. Vaccination with live attenuated or inactivated vaccines is effective for many viral diseases, including duck plague, duck viral hepatitis, and duck Tembusu virus disease [5, 23, 29]. Selective breeding for disease resistance has shown promise for DHAV-3. Passive immunization with yolk antibodies (IgY) is an emerging strategy for DHAV.
Control measures include strict biosecurity, all-in-all-out management, proper sanitation, and vector control [5, 22]. Surveillance and early detection using molecular diagnostics are critical for preventing outbreaks [7, 15, 17, 26].
Related Clinical & Scientific Guides
- Duck Diseases: A Comprehensive Overview for Veterinary Practitioners
- Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact
- Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs